Hoppe B - Search Results

1

Systematic assessment of urinary hydroxy-oxo-glutarate for diagnosis and follow-up of primary hyperoxaluria type III.

Ventzke A, Feldkötter M, Wei A, Becker J, Beck BB, Hoppe B. Ventzke A, et al. Among authors: hoppe b. Pediatr Nephrol. 2017 Dec;32(12):2263-2271. doi: 10.1007/s00467-017-3731-3. Epub 2017 Jul 15. Pediatr Nephrol. 2017. PMID: 28711958

2

Genetic analysis: a diagnostic tool for primary hyperoxaluria type 1.

von Schnakenburg C, Rumsby G, Hoppe B, Latta K, Kemper M. von Schnakenburg C, et al. Among authors: hoppe b. Pediatr Nephrol. 2003 May;18(5):482-3; author reply 484. doi: 10.1007/s00467-003-1107-3. Epub 2003 Apr 5. Pediatr Nephrol. 2003. PMID: 12687460 No abstract available.

3

A United States survey on diagnosis, treatment, and outcome of primary hyperoxaluria.

Hoppe B, Langman CB. Hoppe B, et al. Pediatr Nephrol. 2003 Oct;18(10):986-91. doi: 10.1007/s00467-003-1234-x. Epub 2003 Aug 15. Pediatr Nephrol. 2003. PMID: 12920626

4

Urinary NAG in children with urolithiasis, nephrocalcinosis, or risk of urolithiasis.

Sikora P, Glatz S, Beck BB, Stapenhorst L, Zajaczkowska M, Hesse A, Hoppe B. Sikora P, et al. Among authors: hoppe b. Pediatr Nephrol. 2003 Oct;18(10):996-9. doi: 10.1007/s00467-003-1229-7. Epub 2003 Aug 13. Pediatr Nephrol. 2003. PMID: 12920632

5

Diagnostic and therapeutic approaches in patients with secondary hyperoxaluria.

Hoppe B, Leumann E, von Unruh G, Laube N, Hesse A. Hoppe B, et al. Front Biosci. 2003 Sep 1;8:e437-43. doi: 10.2741/1135. Front Biosci. 2003. PMID: 12957811 Review.

6

Successful plasma therapy for atypical hemolytic uremic syndrome caused by factor H deficiency owing to a novel mutation in the complement cofactor protein domain 15.

Licht C, Weyersberg A, Heinen S, Stapenhorst L, Devenge J, Beck B, Waldherr R, Kirschfink M, Zipfel PF, Hoppe B. Licht C, et al. Among authors: hoppe b. Am J Kidney Dis. 2005 Feb;45(2):415-21. doi: 10.1053/j.ajkd.2004.10.018. Am J Kidney Dis. 2005. PMID: 15685522

7

Primary hyperoxaluria type 1: is genotyping clinically helpful?

Leumann E, Hoppe B. Leumann E, et al. Among authors: hoppe b. Pediatr Nephrol. 2005 May;20(5):555-7. doi: 10.1007/s00467-005-1813-0. Epub 2005 Mar 17. Pediatr Nephrol. 2005. PMID: 15772831 Review.

8

Hypocitraturia as a risk factor for nephrocalcinosis after kidney transplantation.

Stapenhorst L, Sassen R, Beck B, Laube N, Hesse A, Hoppe B. Stapenhorst L, et al. Among authors: hoppe b. Pediatr Nephrol. 2005 May;20(5):652-6. doi: 10.1007/s00467-005-1831-y. Epub 2005 Mar 22. Pediatr Nephrol. 2005. PMID: 15782300

9

Primary hyperoxaluria--the German experience.

Hoppe B, Latta K, von Schnakenburg C, Kemper MJ. Hoppe B, et al. Am J Nephrol. 2005 May-Jun;25(3):276-81. doi: 10.1159/000086358. Epub 2005 Jun 15. Am J Nephrol. 2005. PMID: 15961947

10

Detection of polyomavirus BK and JC in children with kidney diseases and renal transplant recipients.

Müller A, Beck B, Theilemann K, Stapenhorst L, Licht C, Michalk D, Franzen C, Hoppe B. Müller A, et al. Among authors: hoppe b. Pediatr Infect Dis J. 2005 Sep;24(9):778-81. doi: 10.1097/01.inf.0000178071.05483.1c. Pediatr Infect Dis J. 2005. PMID: 16148843

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

627 results

Search Page

Filters